Clinical-epidemiological characterization and etiological agents of severe acute respiratory infections in adults in Paraguay
DOI:
https://doi.org/10.52379/mcs.v8i2.358Keywords:
respiratory viruses, acute respiratory failure, mortalityAbstract
Introduction: Sentinel Surveillance of Severe Acute Respiratory Infections (SARI) includes the monitoring and characterization of hospitalized cases. Objective: To describe the clinical-epidemiological characteristics and etiological agents of adults with SARI in a sentinel hospital in Paraguay. Methodology: Observational, descriptive, cross-sectional study, with retrospective data collection, of adult patients with SARI hospitalized at the National Hospital of Itauguá between June 2022 and August 2023. The information was taken from the database of the National System of Epidemiological surveillance. Results: The data of 1598 patients with SARI were analyzed, 820 men (51.3%), 875 (54.8%) aged 60 or older, 1054 (66.0%) from the Central department. 79.2% (n=1265) of patients had some risk factor or comorbidity, 764 with hypertension (47.8%). 38.5% (n=632) were admitted to the ICU and mortality was 34.7% (n=554). SARSCoV-2 was confirmed in 13.8% (n=353), rhinovirus (1.7%), influenza A (1.5%), influenza B (0.6%), parainfluenza 3 (0.6%), RSV (0.2%), bocavirus (0.4%) and Influenza AH1N1 (0.6%). There was a significantly higher frequency of deaths in those aged 60 years and over (40.7%), with some risk factor (35.5% vs 25.9%), and in those confirmed with covid-19 (38.2% % vs 30.5%). Conclusion: SARSCoV-2 continues to be the main etiological agent of SARI in a sentinel hospital in Paraguay. Continued knowledge of the epidemiology and viral agents involved is crucial to developing effective prevention and treatment strategies.
Downloads
References
Ministerio de Salud Pública y Bienestar Social. Dirección general de vigilancia de la salud (DGVS). Vigilancia Centinela ETI (Enfermedad tipo Influenza) e IRAG (Infección respiratoria aguda grave). URL
Lin WH, Chiu HC, Chen KF, Tsao KC, Chen YY, Li TH, Huang YC, Hsieh YC. Molecular detection of respiratory pathogens in community-acquired pneumonia involving adults. J Microbiol Immunol Infect. 2022; 55(5):829-837 https://doi.org/10.1016/j.jmii.2021.11.009
Sellarès-Nadal J, Burgos J, Velasquez F, Martin-Gómez MT, Antón A, Romero-Herrera D, Eremiev S, Bosch-Nicolau P, Rodriguez-Pardo D, Len O, Falcó V. Impact of viral detection in patients with community-acquired pneumonia: An observational cohort study. Med Clin (Barc). 2023; 17:S0025-7753(23)00468-2. https://doi.org/10.1016/j.medcli.2023.07.018
Menchén DA, Vázquez JB, Allende JMB, García GH. Neumonía vírica. Neumonía en la COVID-19. Viral pneumonia. COVID-19 pneumonia. Medicine (Madr). 2022;13(55):3224-3234. https://doi.org/10.1016/j.med.2022.05.003
Neumann G, Kawaoka Y. Seasonality of influenza and other respiratory viruses. EMBO Mol Med. 2022; 14(4):e15352. https://doi.org/10.15252/emmm.202115352
Efstathiou C, Abidi SH, Harker J, Stevenson NJ. Revisiting respiratory syncytial virus's interaction with host immunity, towards novel therapeutics. Cell Mol Life Sci. 2020;77(24):5045-5058. https://doi.org/10.1007/s00018-020-03557-0
Niederman MS, Torres A. Respiratory infections. Eur Respir Rev. 2022; 31(166):220150. https://doi.org/10.1183/16000617.0150-2022
Cilloniz C, Luna CM, Hurtado JC, et al. Virus respiratorios: su importancia y lecciones aprendidas del COVID-19. Euro Respir Rev 2022; 31:220051. https://doi.org/10.1183/16000617.0051-2022
Yedlapati SH, Khan SU, Talluri S, Lone AN, Khan MZ, Khan MS, Navar AM, Gulati M, Johnson H, Baum S, Michos ED. Effects of Influenza Vaccine on Mortality and Cardiovascular Outcomes in Patients With Cardiovascular Disease: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2021;10(6):e019636. https://doi.org/10.1161/jaha.120.019636
Pierce A, Haworth-Brockman M, Marin D, Rueda ZV, Keynan Y. Changes in the incidence of seasonal influenza in response to COVID-19 social distancing measures: an observational study based on Canada's national influenza surveillance system. Can J Public Health. 2021;112(4):620-628. https://doi.org/10.17269/s41997-021-00509-4
Tempia S, Walaza S, Bhiman JN, McMorrow ML, Moyes J, Mkhencele T, Meiring S, Quan V, Bishop K, McAnerney JM, von Gottberg A, Wolter N, Du Plessis M, Treurnicht FK, Hellferscee O, Dawood H, Naby F, Variava E, Siwele C, Baute N, Nel J, Reubenson G, Zar HJ, Cohen C. Decline of influenza and respiratory syncytial virus detection in facility-based surveillance during the COVID-19 pandemic, South Africa, January to October 2020. Euro Surveill. 2021;26(29):2001600. https://doi.org/10.2807/1560-7917.ES.2021.26.29.2001600
Akhtar Z, Chowdhury F, Rahman M, Ghosh PK, Ahmmed MK, Islam MA, Mott JA, Davis W. Seasonal influenza during the COVID-19 pandemic in Bangladesh. PLoS One. 2021;16(8):e0255646. https://doi.org/10.1371/journal.pone.0255646.
Montiel Jarolin D, Samudio M, Torres E, Jarolin M, Taboada V, Sánchez L. Características clínico-epidemiológicas de pacientes fallecidos por COVID-19 en un hospital de referencia en Paraguay entre enero de 2021 a julio de 2022. Rev. cient. cienc. Salud. 2023;5:e5101. https://doi.org/10.53732/rccsalud/2023.e5101
CDC, 2009; Vacuna Contra La Influenza. OPS/OMS. Organización Panamericana de La Salud. URL
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Dora Montiel-Jarolin, Margarita Samudio, Karin Volkart, Rosa Leguizamón, Magali Jarolin, Estela Torres, Luis Sánchez
This work is licensed under a Creative Commons Attribution 4.0 International License.
